Quantum BioPharma Ltd.
QNTM
$9.70
-$1.71-14.99%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.16% | -56.82% | -50.83% | 8.97% | 98.45% |
| Total Receivables | -9.15% | -5.27% | -10.38% | -46.29% | 7.99% |
| Inventory | 0.91% | -18.10% | -19.88% | -- | -- |
| Prepaid Expenses | -90.76% | 260.51% | 176.35% | -58.74% | -20.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.49% | 83.51% | 211.94% | 1,796.58% | -- |
| Total Current Assets | -9.67% | 4.15% | -17.60% | -12.94% | 38.13% |
|
|
|||||
| Total Current Assets | -9.67% | 4.15% | -17.60% | -12.94% | 38.13% |
| Net Property, Plant & Equipment | -16.39% | 108.78% | -16.18% | -5.03% | 87.82% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.25% | -2.17% | -2.10% | -2.10% | -2.06% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -7.48% | 2.85% | -13.12% | -10.03% | 24.79% |
|
|
|||||
| Total Accounts Payable | 39.46% | 41.64% | -59.41% | 141.17% | -62.54% |
| Total Accrued Expenses | 11.86% | 27.57% | -6.45% | -43.46% | 139.82% |
| Short-term Debt | 1.58% | 78.74% | 75.75% | 105.99% | -51.19% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 81.47% | 66.72% | -6.61% | 184.00% | 655.21% |
| Total Finance Division Other Current Liabilities | -99.98% | 16.18% | 349.55% | 1,491,900.00% | -- |
| Total Other Current Liabilities | -99.98% | 16.18% | 349.55% | 1,491,900.00% | -- |
| Total Current Liabilities | -49.84% | 28.09% | 54.88% | 81.45% | -27.04% |
|
|
|||||
| Total Current Liabilities | -49.84% | 28.09% | 54.88% | 81.45% | -27.04% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.58% | 78.74% | 75.75% | 105.99% | -51.19% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -49.84% | 28.09% | 54.88% | 81.45% | -27.04% |
|
|
|||||
| Common Stock & APIC | 5.23% | 4.08% | 1.90% | 0.74% | 5.16% |
| Retained Earnings | -2.80% | -5.12% | -4.98% | -3.21% | -2.35% |
| Treasury Stock & Other | 12.53% | -18.71% | -30.37% | -27.63% | 12.30% |
| Total Common Equity | 129.87% | -34.34% | -50.07% | -29.52% | 48.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 129.87% | -34.34% | -50.07% | -29.52% | 48.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 33.28% | -42.64% | -15.69% | -10.17% | -24.89% |
| Total Equity | 266.72% | -54.80% | -56.62% | -31.97% | 50.42% |
|
|
|||||